ID
33550
Description
Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria
Keywords
Versions (3)
- 12/12/18 12/12/18 -
- 6/6/19 6/6/19 -
- 6/14/19 6/14/19 - Sarah Riepenhausen
Copyright Holder
GSK group of companies
Uploaded on
December 12, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)
Medication - Final Analysis
- StudyEvent: ODM
Description
Medication
Description
Medication details
Description
Trade/Generic Name
Data type
text
Description
Medical Indication
Data type
text
Description
Prophylactic?
Data type
boolean
Description
Total daily dose
Data type
text
Description
Route
Data type
integer
Description
Start date
Data type
date
Description
End date
Data type
date
Description
Ongoing?
Data type
boolean
Similar models
Medication - Final Analysis
- StudyEvent: ODM